(Q34581061)

English

Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel gro

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel gro (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

object named as

A Ferrari

4

0 references

8

object named as

G Nappi

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

G Sandrini

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

R Cerbo

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

E Del Bene

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

S Genco

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

I Grazioli

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

P Martelletti

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

L Pinessi

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

P Sarchielli

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

P Tamburro

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

C Uslenghi

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

G Zanchin

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1256-1269

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

The International Classification of Headache Disorders: 2nd edition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Indomethacin-responsive headache syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

A benefit-risk assessment of caffeine as an analgesic adjuvant.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

The effects on the central nervous system of nitroglycerin--putative mechanisms and mediators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Central effect of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen, and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Analgesic effect of indomethacin shown using the nociceptive flexion reflex in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

7 July 2018

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

27 October 2018

Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

27 October 2018

Prochlorperazine induces central antinociception mediated by the muscarinic system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

27 October 2018

The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

27 October 2018

Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974802

27 October 2018

Caffeine induces central cholinergic analgesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17627707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central mechanism of indomethacin analgesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17627707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TERMINATION OF MIGRAINE HEADACHE BY A NEW ANTI-INFLAMMATORY VASOCONSTRICTOR AGENT

1 reference

https://pubmed.ncbi.nlm.nih.gov/17627707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Migraine and non-steroidal anti-inflammatory agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17627707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for controlled trials of drugs in migraine: second edition

1 reference

https://pubmed.ncbi.nlm.nih.gov/17627707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caffeine as an analgesic adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/17627707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/17627707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability of the migraine disability assessment score in a population-based sample of headache sufferers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17627707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1742-1241.2007.01458.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

release_76dgvxjztbctrioqi3pxqug76u

1 reference

https://api.fatcat.wiki/v0/release/76dgvxjztbctrioqi3pxqug76u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34581061&oldid=1955008491"